— Know what they know.
Not Investment Advice

CATX AMEX

Perspective Therapeutics, Inc.
1W: +0.5% 1M: -17.6% 3M: -31.3% YTD: +39.1% 1Y: +37.1% 3Y: -23.9% 5Y: -49.7%
$3.98
+0.11 (+2.84%)
 
Weekly Expected Move ±9.7%
$3 $3 $4 $4 $5
AMEX · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 39 · $307.5M mcap · 50M float · 2.89% daily turnover · Short 55% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
33.6 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -148.3%  ·  5Y Avg: -21.1%
Cost Advantage
12
Intangibles
30
Switching Cost
48
Network Effect
43
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CATX has No discernible competitive edge (33.6/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. Negative ROIC of -148.3% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$12
Avg Target
$12
High
Based on 5 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$12.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-17 Truist Financial Greg Renza $21 $12 -9 +135.8% $5.09
2026-02-19 Piper Sandler Biren Amin Initiated $16 +218.1% $5.03
2026-01-30 H.C. Wainwright Initiated $12 +181.7% $4.26
2025-11-20 UBS David Lai $20 $7 -13 +230.2% $2.12
2025-10-10 BTIG Jeet Mukherjee Initiated $14 +233.3% $4.20
2024-10-23 UBS David Dai Initiated $20 +71.1% $11.69
2024-10-14 Oppenheimer Jeff Jones $19 $22 +3 +73.8% $12.66
2024-09-25 Truist Financial Nicole Germino Initiated $21 +71.0% $12.28
2024-07-25 Bank of America Securities Alec Stranahan Initiated $24 +87.2% $12.82
2024-06-18 Oppenheimer Jeff Jones $2 $19 +17 +59.3% $11.93
2024-06-14 RBC Capital Gregory Renza Initiated $3 +161.2% $1.15
2024-05-15 Oppenheimer Jeff Jones Initiated $2 +27.4% $1.57

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
4
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CATX receives an overall rating of B-. Strongest factors: D/E (4/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-11 C+ B-
2026-04-01 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

22 Grade D
Profitability
0
Balance Sheet
0
Earnings Quality
69
Growth
52
Value
31
Momentum
50
Safety
30
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CATX scores highest in Earnings Quality (69/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.70
Distress Zone
Piotroski F-Score
2/9
Beneish M-Score
-5.29
Unlikely Manipulator
Ohlson O-Score
-4.33
Bankruptcy prob: 1.3%
Low Risk
Credit Rating
BB
Score: 43.0/100
Trend: Improving
Earnings Quality
OCF/NI: 0.83x
Accruals: -6.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CATX scores 1.70, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CATX scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CATX's score of -5.29 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CATX's implied 1.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CATX receives an estimated rating of BB (score: 43.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.71x
PEG
0.23x
P/S
534.70x
P/B
1.19x
P/FCF
-4.12x
P/OCF
EV/EBITDA
-2.61x
EV/Revenue
502.47x
EV/EBIT
-2.53x
EV/FCF
-2.75x
Earnings Yield
-25.72%
FCF Yield
-24.30%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CATX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.988
NI / EBT
×
Interest Burden
0.984
EBT / EBIT
×
EBIT Margin
-198.755
EBIT / Rev
×
Asset Turnover
0.002
Rev / Assets
×
Equity Multiplier
1.222
Assets / Equity
=
ROE
-44.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CATX's ROE of -44.7% is driven by Asset Turnover (0.002), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.99 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.98
Median 1Y
$2.37
5th Pctile
$0.42
95th Pctile
$13.52
Ann. Volatility
103.1%
Analyst Target
$12.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Johan (Thijs) Spoor
CEO and Director
$680,000 $— $2,404,692
Juan Graham Financial
ief Financial Officer
$334,734 $— $2,234,930
Joel Sendek Financial
ancial Officer
$163,014 $— $1,986,552
Markus Puhlmann, M.D.
Chief Medical Officer
$516,700 $— $1,068,083

CEO Pay Ratio

13:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,404,692
Avg Employee Cost (SGA/emp): $185,479
Employees: 163

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
163
+16.4% YoY
Revenue / Employee
Profit / Employee
$-632,644
NI: $-103,121,000
SGA / Employee
$185,479
Avg labor cost proxy
R&D / Employee
$516,656
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -36.6% -53.2% -61.1% -66.1% -18.3% -22.7% -27.7% -25.2% -29.6% -40.4% -71.6% -90.0% -90.9% -98.3% -43.3% -46.6% -51.9% -57.8% -41.4% -44.7% -44.66%
ROA -28.0% -40.6% -46.7% -50.5% -17.1% -21.1% -25.4% -23.1% -28.1% -38.3% -59.6% -74.9% -75.7% -81.8% -36.1% -38.8% -43.3% -48.2% -33.9% -36.6% -36.55%
ROIC -66.6% -96.8% -1.1% -1.2% -1.2% -1.5% -77.8% -1.5% -2.2% -2.6% -47.2% -49.3% -52.6% -61.9% -1.1% -1.2% -1.3% -1.4% -1.4% -1.5% -1.48%
ROCE 0.0% -16.0% -16.0% -24.6% -5.3% -1.8% -8.0% -26.0% -46.5% -46.5% -38.2% -38.9% -38.8% -57.1% -24.9% -26.9% -30.1% -33.5% -43.7% -48.0% -47.96%
Gross Margin 49.7% 40.1% 43.3% 49.5% 37.0% 24.1% 22.0% 13.9% -22.7% 24.2% 1.0% -1.1% -1.5% -2.7% -13.8% -13.82%
Operating Margin -40.3% -88.7% -58.1% -41.5% -84.1% -2.5% -1.7% -6.1% -7.6% -5.5% -23.2% -63.8% -82.9% -133.3% -372.1% -372.12%
Net Margin -39.2% -87.5% -57.0% -41.5% -80.4% -2.3% -1.2% -20.3% -7.4% -5.4% -73.2% -53.1% -74.1% -124.3% -344.6% -344.59%
EBITDA Margin -40.3% -86.4% -58.1% -47.3% -84.1% -2.5% -1.7% -5.8% -7.4% -5.1% -25.5% -50.6% -72.9% -120.2% -357.3% -357.30%
FCF Margin -32.0% -47.9% -51.3% -56.5% -73.9% -77.3% -1.0% -2.3% -3.4% -4.5% -6.8% -6.2% -10.9% -120.4% -303.3% -177.9% -124.1% -110.5% -182.6% -182.58%
OCF Margin -28.2% -44.8% -48.0% -54.0% -71.4% -74.3% -1.0% -2.2% -3.3% -4.4% -6.6% -3.6% -6.3% -2.1% -157.1% -102.5% -100.4% -98.1% -160.6% -160.64%
ROE 3Y Avg snapshot only -53.56%
ROE 5Y Avg snapshot only -44.83%
ROA 3Y Avg snapshot only -42.09%
ROIC Economic snapshot only -45.44%
Cash ROA snapshot only -34.60%
Cash ROIC snapshot only -1.45%
CROIC snapshot only -1.64%
NOPAT Margin snapshot only -164.89%
Pretax Margin snapshot only -195.55%
R&D / Revenue snapshot only 149.01%
SGA / Revenue snapshot only 51.09%
SBC / Revenue snapshot only 15.59%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -129.36 -70.46 -37.69 -32.59 -24.01 -14.43 -14.51 -41.16 -20.83 -6.26 -4.75 -10.08 -11.26 -14.78 -2.84 -1.81 -2.56 -2.41 -1.97 -3.89 -3.710
P/S Ratio 43.58 33.86 19.93 18.12 15.72 12.69 15.12 44.41 53.29 21.27 39.58 157.28 295.85 2797.91 450.64 384.67 303.01 241.36 751.35 534.704
P/B Ratio 34.30 27.12 16.68 15.60 2.63 1.96 2.48 6.41 6.71 2.75 2.94 7.84 8.84 12.54 0.78 0.53 0.84 0.88 0.98 2.09 1.187
P/FCF -136.16 -70.63 -38.88 -32.08 -21.27 -16.42 -14.59 -19.71 -15.67 -4.72 -5.81 -25.30 -27.04 -23.23 -3.10 -1.49 -2.16 -2.44 -2.19 -4.12 -4.115
P/OCF
EV/EBITDA -125.28 -68.53 -35.82 -30.17 -15.00 -7.14 -8.51 -15.27 -11.12 -3.08 -5.33 -14.24 -16.24 -20.76 -0.03 0.82 -0.21 -0.30 -0.59 -2.61 -2.611
EV/Revenue 42.72 33.01 19.12 17.33 10.19 6.69 10.24 38.87 46.94 15.08 38.38 155.49 292.87 2778.07 -200.98 32.05 38.03 71.20 502.47 502.469
EV/EBIT -148.53 -89.86 -54.76 -31.59 -55.16 -20.83 -21.28 -12.53 -4.14 -6.81 -18.19 -20.63 -19.94 -0.03 0.79 -0.21 -0.30 -0.58 -2.53 -2.528
EV/FCF -133.46 -68.86 -37.30 -30.68 -13.79 -8.66 -9.88 -17.25 -13.80 -3.35 -5.63 -25.02 -26.77 -23.07 -0.03 0.66 -0.18 -0.31 -0.64 -2.75 -2.752
Earnings Yield -0.8% -1.4% -2.7% -3.1% -4.2% -6.9% -6.9% -2.4% -4.8% -16.0% -21.1% -9.9% -8.9% -6.8% -35.2% -55.3% -39.1% -41.5% -50.8% -25.7% -25.72%
FCF Yield -0.7% -1.4% -2.6% -3.1% -4.7% -6.1% -6.9% -5.1% -6.4% -21.2% -17.2% -4.0% -3.7% -4.3% -32.3% -67.3% -46.3% -41.0% -45.8% -24.3% -24.30%
PEG Ratio snapshot only 0.230
Price/Tangible Book snapshot only 2.587
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 9.21 9.21 9.21 9.21 34.47 34.47 19.89 19.89 19.89 19.89 1.07 1.07 1.07 1.07 12.68 12.68 12.68 12.68 5.17 5.17 5.174
Quick Ratio 8.71 8.71 8.71 8.71 33.89 33.89 19.36 19.36 19.36 19.36 1.07 1.07 1.07 1.07 12.68 12.68 12.68 12.68 5.17 5.17 5.174
Debt/Equity 0.07 0.07 0.07 0.07 0.01 0.01 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.008
Net Debt/Equity -0.68 -0.68 -0.68 -0.68 -0.93 -0.93 -0.80 -0.80 -0.80 -0.80 -0.09 -0.09 -0.09 -0.09 -0.77 -0.77 -0.77 -0.77 -0.69 -0.69 -0.691
Debt/Assets 0.06 0.06 0.06 0.06 0.01 0.01 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.006
Debt/EBITDA -0.26 -0.18 -0.16 -0.14 -0.09 -0.07 -0.00 -0.00 -0.00 -0.00 -0.06 -0.06 -0.06 -0.06 -0.05 -0.05 -0.04 -0.04 -0.02 -0.01 -0.015
Net Debt/EBITDA 2.53 1.76 1.52 1.37 8.14 6.40 4.05 2.18 1.51 1.26 0.17 0.16 0.17 0.15 2.85 2.65 2.36 2.12 1.42 1.29 1.293
Interest Coverage -8.62 -8.17 -25.82 -44.15 -56.29 -383.23 -344.24 -354.36 -323.76 -1675.79 -589.75 -400.50 -452.60 -276.73 -323.75 -323.751
Equity Multiplier 1.21 1.21 1.21 1.21 1.04 1.04 1.06 1.06 1.06 1.06 1.30 1.30 1.30 1.30 1.17 1.17 1.17 1.17 1.29 1.29 1.290
Cash Ratio snapshot only 5.047
Debt Service Coverage snapshot only -313.425
Cash to Debt snapshot only 88.905
FCF to Debt snapshot only -64.486
Defensive Interval snapshot only 447.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.83 0.85 0.88 0.91 0.26 0.24 0.24 0.21 0.11 0.11 0.07 0.05 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.002
Inventory Turnover 7.53 8.14 8.75 9.11 7.13 6.86 5.58 5.68 4.97 5.08 6.90 4.67 2.05 0.00
Receivables Turnover 5.32 5.41 5.65 5.82 6.38 5.88 5.78 5.09 4.57 4.70 4.41 2.96 1.78 0.27 0.00 0.53 0.99 1.31 13.79 9.43 9.426
Payables Turnover 8.59 9.28 9.99 10.39 9.22 8.87 5.68 5.79 5.15 5.27 1.15 0.78 0.34 0.00 0.00 0.08 0.17 0.26 0.43 0.51 0.509
DSO 69 67 65 63 57 62 63 72 80 78 83 123 205 1369 684 370 278 26 39 38.7 days
DIO 48 45 42 40 51 53 65 64 73 72 53 78 178 0 0 0 0 0 0.0 days
DPO 42 39 37 35 40 41 64 63 71 69 317 469 1066 4301 2149 1406 843 717 716.6 days
Cash Conversion Cycle 75 73 70 68 69 74 64 73 82 80 -181 -268 -683 -3618 -1779 -1128 -816 -678 -677.9 days
Fixed Asset Turnover snapshot only 0.007
Cash Velocity snapshot only 0.004
Capital Intensity snapshot only 464.299
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3.9% 5.0% 8.0% 14.3% 7.4% -2.8% -16.1% -28.3% -36.2% -28.9% -37.8% -52.5% -67.4% -95.2% -1.0% -90.9% -71.9% 1.5% 68.1% 68.13%
Net Income 1.7% -47.1% -70.6% -74.0% -1.1% -78.0% -65.3% -39.2% -1.5% -1.7% -4.0% -5.9% -2.4% -1.7% -70.5% -45.8% -60.9% -65.9% -30.1% -30.5% -30.48%
EPS -21.9% -84.6% -1.6% -74.0% -1.1% -78.0% -65.3% -39.2% -1.5% -1.7% -4.0% -6.6% -1.8% -1.1% -32.5% 0.2% -51.7% -57.7% -24.5% 8.9% 8.87%
FCF 17.8% -35.7% -79.6% -1.2% -1.5% -56.8% -69.6% -1.9% -1.9% -3.1% -3.1% -31.0% -5.0% -27.3% -91.4% -3.5% -3.6% -1.6% -27.8% -1.2% -1.22%
EBITDA -1.9% -50.3% -74.3% -79.3% -1.1% -89.2% -89.2% -2.2% -3.0% -2.7% -2.7% -1.0% -39.5% -30.2% -94.7% -1.1% -1.3% -1.3% -29.0% -31.7% -31.71%
Op. Income 0.9% -49.3% -73.5% -75.3% -1.1% -82.9% -85.9% -2.3% -3.2% -3.0% -2.8% -1.1% -52.1% -47.9% -1.2% -1.3% -1.4% -1.2% -25.0% -20.4% -20.36%
OCF Growth snapshot only -71.93%
Asset Growth snapshot only -21.73%
Equity Growth snapshot only -28.77%
Debt Growth snapshot only -59.92%
Shares Change snapshot only 43.18%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 19.3% 17.7% 17.2% 16.3% 13.9% 7.2% 2.3% -5.4% -10.7% -10.1% -17.4% -27.0% -39.3% -67.9% -68.6% -61.2% -56.1% -54.6% -58.2% -58.22%
Revenue 5Y 16.1% 17.4% 19.3% 19.5% 17.8% 15.3% 10.7% 6.7% 3.0% 2.4% -3.4% -11.7% -21.0% -47.0% -48.4% -42.1% -38.7% -38.9% -43.1% -43.08%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 40.6% 32.7% 28.5% 24.6% 14.9% 2.1% -8.1% -26.0% -47.7% -46.7% -48.4% -54.4% -46.2% -59.0%
Gross Profit 5Y 1.1% 1.2% 1.4% 76.7% 40.7% 30.6% 14.9% 1.0% -16.9% -18.0% -21.1% -29.3% -23.5% -38.3%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 27.7% 27.7% 27.7% 27.7% 92.5% 92.5% 83.4% 83.4% 88.3% 88.3% 1.2% 1.2% 84.8% 84.8% 1.8% 1.8% 71.8% 71.8% 66.3% 66.3% 66.26%
Assets 5Y -3.0% -3.0% -3.0% -3.0% 40.5% 40.5% 36.5% 36.5% 50.8% 50.8% 67.4% 67.4% 59.7% 59.7% 1.0% 1.0% 1.1% 1.1% 98.3% 98.3% 98.33%
Equity 3Y 36.4% 36.4% 36.4% 36.4% 1.0% 1.0% 92.3% 92.3% 1.1% 1.1% 1.4% 1.4% 80.6% 80.6% 1.8% 1.8% 65.3% 65.3% 55.9% 55.9% 55.90%
Book Value 3Y 36.9% 45.2% 46.0% 46.0% 1.2% 1.2% 1.1% 1.1% 1.3% 1.3% 1.7% 1.4% 69.3% 66.0% 1.6% 1.6% 51.9% 49.4% 41.3% 26.2% 26.16%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.93 0.97 0.99 0.97 0.95 0.87 0.66 0.34 0.12 0.09 0.01 0.12 0.26 0.40 0.53 0.70 0.77 0.76 0.84 0.90 0.905
Earnings Stability 0.41 0.29 0.16 0.09 0.06 0.03 0.09 0.09 0.37 0.49 0.48 0.47 0.60 0.67 0.75 0.76 0.81 0.83 0.91 0.91 0.906
Margin Stability 0.43 0.44 0.44 0.51 0.66 0.71 0.77 0.72 0.54 0.56 0.58 0.55 0.58 0.35 0.54 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.99 0.81 0.50 0.50 0.50 0.50 0.50 0.84 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.82 0.50 0.50 0.88 0.88 0.878
Earnings Smoothness
ROE Trend 0.37 0.20 0.10 0.05 0.32 0.35 0.34 0.39 -0.13 -0.18 -0.31 -0.46 -0.57 -0.56 0.12 0.17 0.23 0.28 -0.05 -0.00 -0.002
Gross Margin Trend 0.04 -0.02 -0.04 -0.06 -0.09 -0.10 -0.14 -0.23 -0.36 -0.33 -0.28 -0.23 0.09 0.74 -1.33 -1.55 -2.22 -3.07 -3.072
FCF Margin Trend 0.26 -0.01 -0.08 -0.20 -0.38 -0.35 -0.63 -1.82 -2.87 -3.88 -6.04 -4.81 -8.87 -117.79 -299.05 -170.75 -61.65 -27.83 -27.833
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.84 0.93 0.91 0.97 1.09 0.84 0.96 2.03 1.28 1.28 0.79 0.23 0.24 0.01 0.23 0.63 0.68 0.80 0.80 0.83 0.831
FCF/OCF 1.13 1.07 1.07 1.05 1.03 1.04 1.04 1.03 1.04 1.04 1.03 1.75 1.73 58.31 3.97 1.93 1.74 1.24 1.13 1.14 1.137
FCF/Net Income snapshot only 0.945
CapEx/Revenue 3.8% 3.1% 3.2% 2.5% 2.5% 3.0% 3.6% 6.4% 13.8% 15.4% 19.2% 2.7% 4.6% 118.4% 146.2% 85.1% 31.0% 19.7% 32.6% 32.58%
CapEx/Depreciation snapshot only 5.140
Accruals Ratio -0.05 -0.03 -0.04 -0.01 0.02 -0.03 -0.01 0.24 0.08 0.11 -0.12 -0.58 -0.58 -0.81 -0.28 -0.14 -0.14 -0.10 -0.07 -0.06 -0.062
Sloan Accruals snapshot only -0.319
Cash Flow Adequacy snapshot only -4.930
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -23.8% -16.2% -26.4% -0.2% -0.0% -0.1% -0.0% -0.0% -0.1% -0.3% -0.4% -9.2% -43.4% -30.6% -1.2% -1.5% -1.3% -1.1% -4.9% -38.0% -38.05%
Total Shareholder Return -23.8% -16.2% -26.4% -0.2% -0.0% -0.1% -0.0% -0.0% -0.1% -0.3% -0.4% -9.2% -43.4% -30.6% -1.2% -1.5% -1.3% -1.1% -4.9% -38.0% -38.05%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 0.98 0.97 0.96 0.90 0.43 0.61 0.69 1.14 1.39 1.40 1.35 0.98 0.98 0.97 0.98 0.99 0.99 0.988
Interest Burden (EBT/EBIT) 2.16 2.49 1.80 2.09 7.54 2.36 1.38 1.12 1.36 1.30 1.31 1.32 1.00 1.00 1.00 1.00 1.00 1.00 0.98 0.984
EBIT Margin 0.00 -0.22 -0.21 -0.32 -0.32 -0.12 -0.49 -1.83 -3.75 -3.64 -5.64 -8.55 -14.20 -139.30 -253.49 -153.99 -128.62 -123.72 -198.75 -198.755
Asset Turnover 0.83 0.85 0.88 0.91 0.26 0.24 0.24 0.21 0.11 0.11 0.07 0.05 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.002
Equity Multiplier 1.31 1.31 1.31 1.31 1.07 1.07 1.09 1.09 1.05 1.05 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.22 1.22 1.222
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.06 $-0.09 $-0.10 $-0.11 $-0.13 $-0.16 $-0.17 $-0.16 $-0.32 $-0.44 $-0.85 $-1.18 $-0.89 $-0.90 $-1.12 $-1.18 $-1.34 $-1.42 $-1.40 $-1.07 $-1.07
Book Value/Share $0.23 $0.23 $0.23 $0.23 $1.17 $1.17 $1.00 $1.00 $1.00 $1.00 $1.37 $1.52 $1.13 $1.06 $4.12 $4.02 $4.11 $3.91 $2.80 $2.00 $3.35
Tangible Book/Share $0.23 $0.23 $0.23 $0.23 $1.17 $1.17 $0.99 $0.99 $0.99 $0.99 $0.01 $0.02 $0.01 $0.01 $3.41 $3.33 $3.41 $3.24 $2.26 $1.61 $1.61
Revenue/Share $0.18 $0.19 $0.19 $0.20 $0.20 $0.18 $0.16 $0.14 $0.13 $0.13 $0.10 $0.08 $0.03 $0.00 $0.00 $0.00 $0.01 $0.01 $0.01 $0.01 $0.01
FCF/Share $-0.06 $-0.09 $-0.10 $-0.11 $-0.15 $-0.14 $-0.17 $-0.32 $-0.43 $-0.58 $-0.69 $-0.47 $-0.37 $-0.57 $-1.03 $-1.43 $-1.59 $-1.40 $-1.26 $-1.01 $-1.04
OCF/Share $-0.05 $-0.08 $-0.09 $-0.11 $-0.14 $-0.13 $-0.16 $-0.31 $-0.41 $-0.56 $-0.67 $-0.27 $-0.21 $-0.01 $-0.26 $-0.74 $-0.92 $-1.14 $-1.12 $-0.89 $-0.89
Cash/Share $0.17 $0.17 $0.17 $0.17 $1.10 $1.10 $0.80 $0.80 $0.80 $0.80 $0.17 $0.19 $0.14 $0.13 $3.21 $3.14 $3.21 $3.05 $1.96 $1.40 $2.62
EBITDA/Share $-0.06 $-0.09 $-0.10 $-0.12 $-0.13 $-0.17 $-0.20 $-0.37 $-0.53 $-0.63 $-0.73 $-0.83 $-0.61 $-0.64 $-1.11 $-1.16 $-1.34 $-1.42 $-1.37 $-1.07 $-1.07
Debt/Share $0.02 $0.02 $0.02 $0.02 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.05 $0.05 $0.04 $0.04 $0.06 $0.06 $0.06 $0.05 $0.02 $0.02 $0.02
Net Debt/Share $-0.16 $-0.16 $-0.16 $-0.16 $-1.09 $-1.09 $-0.80 $-0.80 $-0.80 $-0.80 $-0.12 $-0.14 $-0.10 $-0.09 $-3.16 $-3.08 $-3.15 $-3.00 $-1.94 $-1.38 $-1.38
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.696
Altman Z-Prime snapshot only 3.544
Piotroski F-Score 6 4 4 4 4 5 4 3 1 2 4 3 2 2 4 4 4 5 2 2 2
Beneish M-Score -2.75 -2.64 -2.68 -2.65 -2.30 -2.31 -1.85 -0.86 -3.26 -1.30 5.06 -5.29 -5.291
Ohlson O-Score snapshot only -4.329
ROIC (Greenblatt) snapshot only -57.78%
Net-Net WC snapshot only $0.85
EVA snapshot only $-101202470.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 73.27 72.73 73.71 73.88 74.58 62.57 70.19 68.50 69.25 68.45 46.82 56.59 57.06 56.49 42.51 37.76 42.54 42.53 33.00 43.00 43.004
Credit Grade snapshot only 12
Credit Trend snapshot only 5.242
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 40
Sector Credit Rank snapshot only 34

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms